匹多莫德治疗过敏性疾病。

IF 2.6 4区医学 Q2 Medicine

Minerva pediatrica Pub Date : 2020-10-01 Epub Date: 2020-07-29 DOI:10.23736/S0026-4946.20.05967-8

Sara Manti, Giuseppe F Parisi, Maria Papale, Salvatore Leonardi

{"title":"匹多莫德治疗过敏性疾病。","authors":"Sara Manti, Giuseppe F Parisi, Maria Papale, Salvatore Leonardi","doi":"10.23736/S0026-4946.20.05967-8","DOIUrl":null,"url":null,"abstract":"The rising incidence of allergic disease requires more specific, effective and safe therapeutic strategies. In this regard, several kinds of biologically active substances, commonly known as immunostimulants, have been introduced for the prevention and treatment of allergic diseases in pediatric population. Among the heterogeneous group of biologically active molecules to date available, pidotimod (Axil, Valeas S.p.A, Milan) is proved to be able to ameliorate both innate and adaptive immunity and enhances the immune system properties often impaired in patients with allergic disorders.","PeriodicalId":18533,"journal":{"name":"Minerva pediatrica","volume":"72 5","pages":"358-363"},"PeriodicalIF":2.6000,"publicationDate":"2020-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"2","resultStr":"{\"title\":\"Pidotimod in allergic diseases.\",\"authors\":\"Sara Manti, Giuseppe F Parisi, Maria Papale, Salvatore Leonardi\",\"doi\":\"10.23736/S0026-4946.20.05967-8\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"The rising incidence of allergic disease requires more specific, effective and safe therapeutic strategies. In this regard, several kinds of biologically active substances, commonly known as immunostimulants, have been introduced for the prevention and treatment of allergic diseases in pediatric population. Among the heterogeneous group of biologically active molecules to date available, pidotimod (Axil, Valeas S.p.A, Milan) is proved to be able to ameliorate both innate and adaptive immunity and enhances the immune system properties often impaired in patients with allergic disorders.\",\"PeriodicalId\":18533,\"journal\":{\"name\":\"Minerva pediatrica\",\"volume\":\"72 5\",\"pages\":\"358-363\"},\"PeriodicalIF\":2.6000,\"publicationDate\":\"2020-10-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"2\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Minerva pediatrica\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://doi.org/10.23736/S0026-4946.20.05967-8\",\"RegionNum\":4,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"2020/7/29 0:00:00\",\"PubModel\":\"Epub\",\"JCR\":\"Q2\",\"JCRName\":\"Medicine\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Minerva pediatrica","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.23736/S0026-4946.20.05967-8","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2020/7/29 0:00:00","PubModel":"Epub","JCR":"Q2","JCRName":"Medicine","Score":null,"Total":0}

引用次数: 2

摘要

过敏性疾病的发病率不断上升，需要更具体、有效和安全的治疗策略。在这方面，已经引入了几种生物活性物质，通常称为免疫刺激剂，用于预防和治疗儿科人群的过敏性疾病。在迄今为止可获得的异质性生物活性分子中，匹多莫德(Axil, Valeas S.p.A, Milan)被证明能够改善先天和适应性免疫，并增强过敏性疾病患者经常受损的免疫系统特性。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

查看原文本刊更多论文

Pidotimod in allergic diseases.

The rising incidence of allergic disease requires more specific, effective and safe therapeutic strategies. In this regard, several kinds of biologically active substances, commonly known as immunostimulants, have been introduced for the prevention and treatment of allergic diseases in pediatric population. Among the heterogeneous group of biologically active molecules to date available, pidotimod (Axil, Valeas S.p.A, Milan) is proved to be able to ameliorate both innate and adaptive immunity and enhances the immune system properties often impaired in patients with allergic disorders.

求助全文

通过发布文献求助，成功后即可免费获取论文全文。去求助

来源期刊

Minerva pediatrica PEDIATRICS-

CiteScore

2.70

自引率

3.80%

发文量

审稿时长

>12 weeks

期刊介绍： Minerva Pediatrica publishes scientific papers on pediatrics, neonatology, adolescent medicine, child and adolescent psychiatry and pediatric surgery. Manuscripts may be submitted in the form of editorials, original articles, review articles, special articles, letters to the Editor and guidelines. The journal aims to provide its readers with papers of the highest quality and impact through a process of careful peer review and editorial work.